+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ovarian Cancer (Oncology) - Drugs in Development, 2021

  • PDF Icon

    Report

  • 5066 Pages
  • December 2021
  • Region: Global
  • Global Markets Direct
  • ID: 5521232
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Drugs In Development, 2021, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.

Ovarian cancer is any cancerous growth that may occur in different parts of the ovary. The majority of ovarian cancers arise from the epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer include pelvic discomfort or pain, indigestion, gas or nausea, changes in bowel habits, such as constipation, loss of appetite and low back pain. The predisposing factors include age and family history. Treatment includes surgery, chemotherapy and radiation therapy.

Report Highlights

The publisher's Pharmaceutical and Healthcare latest pipeline guide Ovarian Cancer - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Ovarian Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Ovarian Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ovarian Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 26, 245, 261, 8, 31, 371, 80 and 13 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical and Discovery stages comprises 17, 22, 3, 55 and 14 molecules, respectively.

Ovarian Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Ovarian Cancer (Oncology).
  • The pipeline guide reviews pipeline therapeutics for Ovarian Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Ovarian Cancer (Oncology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Ovarian Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Ovarian Cancer (Oncology)

Reasons to Buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Ovarian Cancer (Oncology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Ovarian Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Introduction
Report Coverage
  • Ovarian Cancer - Overview
  • Ovarian Cancer - Therapeutics Development
  • Pipeline Overview
  • Pipeline by Companies
  • Pipeline by Universities/Institutes
  • Products under Development by Companies
  • Products under Development by Universities/Institutes
  • Ovarian Cancer - Therapeutics Assessment
  • Assessment by Target
  • Assessment by Mechanism of Action
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Ovarian Cancer - Companies Involved in Therapeutics Development
  • Ovarian Cancer - Drug Profiles
  • Ovarian Cancer - Dormant Projects
  • Ovarian Cancer - Discontinued Products
  • Ovarian Cancer - Product Development Milestones

Featured News & Press Releases
Appendix
  • Methodology
  • Coverage
  • Secondary Research
  • Primary Research
  • Expert Panel Validation
  • Contact The Publisher
  • Disclaimer

List of Tables
  • Number of Products under Development for Ovarian Cancer, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Products under Development by Companies, 2021
  • Products under Development by Universities/Institutes, 2021
  • Number of Products by Stage and Target, 2021
  • Number of Products by Stage and Mechanism of Action, 2021
  • Number of Products by Stage and Route of Administration, 2021
  • Number of Products by Stage and Molecule Type, 2021
  • Ovarian Cancer - Dormant Projects, 2021
  • Ovarian Cancer - Discontinued Products, 2021

List of Figures
  • Number of Products under Development for Ovarian Cancer, 2021
  • Number of Products under Development by Companies, 2021
  • Number of Products under Development by Universities/Institutes, 2021
  • Number of Products by Top 10 Targets, 2021
  • Number of Products by Stage and Top 10 Targets, 2021
  • Number of Products by Top 10 Mechanism of Actions, 2021
  • Number of Products by Stage and Top 10 Mechanism of Actions, 2021
  • Number of Products by Top 10 Routes of Administration, 2021
  • Number of Products by Stage and Top 10 Routes of Administration, 2021
  • Number of Products by Top 10 Molecule Types, 2021
  • Number of Products by Stage and Top 10 Molecule Types, 2021

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 4D Pharma Plc
  • 4SC AG
  • A2 Biotherapeutics Inc
  • Aadi Bioscience Inc
  • AB Science SA
  • Abbisko Therapeutics Co Ltd
  • AbbVie Inc
  • Abclon Inc
  • Abion Inc
  • ABL Bio Inc
  • ABM Therapeutics Inc
  • Acrivon Therapeutics Inc
  • Acrotech Biopharma LLC
  • Adagene Suzhou Ltd
  • Adaptimmune Therapeutics Plc
  • ADC Therapeutics SA
  • Adlai Nortye Biopharma Co Ltd
  • ADRx Inc
  • Advanced Accelerator Applications SA
  • Advenchen Laboratories LLC
  • Adze Biotechnology Inc
  • Affimed GmbH
  • Affina Biotechnologies Inc
  • AGC Biologics SpA
  • Agenus Inc
  • AIM ImmunoTech Inc
  • AiVita Biomedical Inc
  • Akeso Inc
  • Aldeyra Therapeutics Inc
  • Alkermes Plc
  • Allife Medical Science and Technology Co Ltd
  • Alligator Bioscience AB
  • Allist Shanghai Pharmaceutical Technology Co Ltd
  • Almac Discovery Ltd
  • Alphamab Oncology
  • Alteogen Inc
  • ALX Oncology Holdings Inc
  • Ambrx Biopharma Inc
  • Amgen Inc
  • Amphivena Therapeutics Inc
  • Amplia Therapeutics Ltd
  • AnGes Inc
  • Angex Pharmaceutical Inc
  • Anixa Biosciences Inc
  • AntiCancer Inc
  • Anwita Biosciences Inc
  • AOA Inc
  • AP Biosciences Inc
  • Apexian Pharmaceuticals Inc
  • Apexigen Inc
  • Aphios Corp
  • APIM Therapeutics AS
  • Apmonia Therapeutics SAS
  • Apollomics Inc
  • Aprea Therapeutics Inc
  • Aprogen Inc
  • Aravive Inc
  • Arch Oncology Inc
  • Arcus Biosciences Inc
  • Argenx SE
  • Arsenal Biosciences Inc
  • Artios Pharma Ltd
  • Asana BioSciences LLC
  • Ascenta Therapeutics Inc
  • Ascentage Pharma Group International
  • Ascentawits Pharmaceuticals Ltd
  • Aslan Pharmaceuticals Ltd
  • Astellas Pharma Inc
  • Astex Pharmaceuticals Inc
  • AstraZeneca Plc
  • AtlasMedx Inc
  • Atossa Therapeutics Inc
  • Atreca Inc
  • Atrin Pharmaceuticals LLC
  • Aucentra Therapeutics Pty Ltd
  • AUM Biosciences Pte Ltd
  • Aurigene Discovery Technologies Ltd
  • Avacta Life Sciences Ltd
  • Avesthagen Ltd
  • Avicanna Inc
  • Basilea Pharmaceutica Ltd
  • Bavarian Nordic A/S
  • Bayer AG
  • BBS NanoTechnology Ltd
  • BeiGene Ltd
  • Beijing Biostar Technologies Ltd
  • Beijing Combio Pharmaceuticals Ltd
  • Beijing Foreland Pharma Co Ltd
  • Beijing Mabworks Biotech Co Ltd
  • Beijing Neoantigen Biotechnology Co Ltd
  • Beijing Scitech-MQ Pharmaceuticals Ltd
  • Bellicum Pharmaceuticals Inc
  • BerGenBio ASA
  • Bexion Pharmaceuticals LLC
  • Bicara Therapeutics Inc
  • Bicycle Therapeutics Plc
  • Bio-Path Holdings Inc
  • Bio-Synectics Inc
  • Bio-Thera Solutions Ltd
  • BioAtla Inc
  • BioEclipse Therapeutics Inc
  • BioIntegrator Ltd
  • BioInvent International AB
  • Biokine Therapeutics Ltd
  • BioMed Valley Discoveries Inc
  • BioMoti Ltd
  • BioNTech SE
  • Biosion Inc
  • Biosplice Therapeutics Inc
  • Biotheus Inc
  • BioVaxys Technology Corp
  • Blueprint Medicines Corp
  • Boehringer Ingelheim International GmbH
  • BoYen Therapeutics Inc
  • BridGene Biosciences Inc
  • Bristol-Myers Squibb Co
  • Byondis BV
  • Calithera Biosciences Inc
  • CanBas Co Ltd
  • Canget BioTekpharma LLC
  • Cardiff Oncology Inc
  • Carina Biotech Pty Ltd
  • Carisma Therapeutics Inc
  • Carlina Technologies SAS
  • CaroGen Corp
  • Carrick Therapeutics Ltd
  • Cartherics Pty Ltd
  • CAS-Lamvac Biotech Co Ltd
  • Cedilla Therapeutics
  • Celdara Medical LLC
  • Cellatoz Therapeutics Inc
  • Celldex Therapeutics Inc
  • Celleron Therapeutics Ltd
  • Cellestia Biotech AG
  • Cellid Co Ltd
  • Cellis AG
  • Cellix Bio Pvt Ltd
  • Cello Therapeutics Inc
  • Celprogen Inc
  • Celsion Corp
  • Celtec Inc
  • Celyad Oncology SA
  • Centrymed Pharmaceutical Inc
  • Centurion BioPharma Corp
  • CerRx Inc
  • CHA Biotech Co Ltd
  • Checkmate Pharmaceuticals Inc
  • Cheetah Cell Therapeutics Co Ltd
  • Chengdu Jinrui Foundation Biotechnology Co Ltd
  • Chimerix Inc
  • Chongqing Pharmaceutical Research Institute Co Ltd
  • Chordia Therapeutics Inc
  • Chugai Pharmaceutical Co Ltd
  • Cisen Pharmaceutical Co Ltd
  • Clarity Pharmaceuticals Pty Ltd
  • Clayton Biotechnologies Inc
  • Cloaked Therapeutics LLC
  • Clovis Oncology Inc
  • CMG Pharmaceutical Co Ltd
  • CNS Pharmaceuticals Inc
  • Codiak BioSciences Inc
  • CohBar Inc
  • Coherent Biopharma
  • Compugen Ltd
  • Conjupro Biotherapeutics Inc
  • Constellation Pharmaceuticals Inc
  • Context Therapeutics Inc
  • Corcept Therapeutics Inc
  • Cotinga Pharmaceuticals Inc
  • Creative Therapeutics GmbH
  • Cristal Therapeutics BV
  • CSPC Pharmaceutical Group Ltd
  • Cue Biopharma Inc
  • CureLab Oncology Inc
  • Curis Inc
  • Cybrexa Inc
  • Cyclacel Pharmaceuticals Inc
  • Cynvec LLC
  • Cyteir Therapeutics Inc
  • Cytodyn Inc
  • CytomX Therapeutics Inc
  • Cytovia Therapeutics Inc
  • CZ BioMed Corp
  • DAE HWA Pharmaceutical Co Ltd
  • Daiichi Sankyo Co Ltd
  • DeepCure Inc
  • DEKK-TEC Inc
  • Delta-Fly Pharma Inc
  • DevaCell Inc
  • Disulfican Ltd
  • Dongkook Pharmaceutical Co Ltd
  • Dophen Biomed Inc
  • Dragonboat Biopharmaceutical (Shanghai) Co Ltd
  • Ecrins Therapeutics SAS
  • EirGenix Inc
  • Eisai Co Ltd
  • Eli Lilly and Co
  • Ella Therapeutics Ltd
  • Ellipses Pharma Ltd
  • Elthera AG
  • Elucida Oncology Inc
  • Enara Bio Ltd
  • ENB Therapeutics LLC
  • EntreChem SL
  • EpicentRx Inc
  • Epigen Biosciences Inc
  • Epigene Therapeutics Inc
  • EpiThany Inc
  • Epizyme Inc
  • Epsila Bio Inc
  • Epsilogen Ltd
  • Epygen Biotech Pvt Ltd
  • Esperance Pharmaceuticals Inc
  • Esperas Pharma Inc
  • Essential Biotechnology LLC
  • Etirarx LLC
  • Eureka Therapeutics Inc
  • Evestra Inc
  • Exelixis Inc
  • ExonanoRNA LLC
  • F-star Therapeutics Inc
  • F. Hoffmann-La Roche Ltd
  • Falcon Therapeutics Inc
  • Faron Pharmaceuticals Oy
  • Fate Therapeutics Inc
  • Felicitex Therapeutics Inc
  • For-Robin Inc
  • Fujifilm Holdings Corp
  • FUJIFILM Toyama Chemical Co Ltd
  • Gadeta BV
  • GAiA BioMedicine Inc
  • Geistlich Pharma AG
  • GeneCare Research Institute Co Ltd
  • Genekey Biotech Chengdu Co Ltd
  • Genelux Corp
  • Genentech USA Inc
  • Geneos Therapeutics Inc
  • Genesen Co Ltd
  • Genexine Inc
  • Genisphere LLC
  • Genmab AS
  • GeoVax Labs Inc
  • Gilead Sciences Inc
  • GlaxoSmithKline Plc
  • GLG Pharma SA
  • Glycomantra Inc
  • GlycoNex Inc
  • Glycotope GmbH
  • Glysantis Inc
  • GlyTherix Ltd
  • Gmax Biopharm LLC
  • GO Therapeutics Inc
  • GP Pharm SA
  • Gracell Biotechnologies Inc
  • Gradalis Inc
  • Green Cross LabCell Corp
  • Greenfire Bio LLC
  • Greenwich Lifesciences Inc
  • GT Biopharma Inc
  • Guangdong Prokairong Biomedical Technology Co Ltd
  • Guangdong Yinzhu Pharmaceutical Technology Co Ltd
  • Guangdong Zhongsheng Pharmaceutical Co Ltd
  • Guangzhou BeBetter Medicine Technology Co Ltd
  • Guangzhou Hanghua Bio Pharmaceutical Technology Co
  • HaimBio Ltd
  • Hainan Kaibo Biotechnology Co Ltd
  • HaloVax
  • Hangzhou Neoantigen Therapeutics Co Ltd
  • Hangzhou Zenshine Pharmaceuticals Co Ltd
  • Hanmi Pharmaceuticals Co Ltd
  • Harbin Gloria Pharmaceuticals Co Ltd
  • Harbour BioMed (Guangzhou) Co Ltd
  • Harpoon Therapeutics Inc
  • HCW Biologics Inc
  • HDT Bio Corp
  • Hebei Senlang Biotechnology Co Ltd
  • HEC Pharma Co Ltd
  • Helixmith Co Ltd
  • Henan Topfond Pharmaceutical TCM Co Ltd
  • HengRui YuanZheng Bio-Technology Co Ltd
  • Hillstream BioPharma Inc
  • Hinova Pharmaceuticals Co Ltd
  • Horizon Therapeutics Plc
  • HRAIN Biotechnology Co Ltd
  • Huabo Biopharm (Shanghai) Co Ltd
  • Huadong Medicine Co Ltd
  • Hubei Soundny Bio-Tech Co Ltd
  • Hummingbird Bioscience Pte Ltd
  • Hunan Siweikang Therapeutics Ltd
  • Hutchison MediPharma Ltd
  • I-Mab
  • Ideaya Biosciences Inc
  • Idera Pharmaceuticals Inc
  • Idience Co Ltd
  • IGF Oncology LLC
  • IGM Biosciences Inc
  • Iksuda Therapeutics Ltd
  • ImCheck Therapeutics SAS
  • Immatics NV
  • IMMD Inc
  • Immix BioPharma Inc
  • Immune Modulatory Therapies LLC
  • Immune Pharmaceuticals Inc
  • ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
  • Immunicum AB
  • Immunitor Inc
  • ImmunityBio Inc
  • Immunocore Holdings Plc
  • ImmunoGen Inc
  • ImmunSYS Inc
  • IMPACT Therapeutics Inc
  • Imugene Ltd
  • IMV Inc
  • Imvax Inc
  • Incyte Corp
  • Indi Molecular Inc
  • Infinity Pharmaceuticals Inc
  • Inmune Bio Inc
  • Innate Pharma SA
  • InnoMedica Holding AG
  • Innovation Pharmaceuticals Inc
  • Innovative Cellular Therapeutics Co Ltd
  • Innovent Biologics Inc
  • Inovio Pharmaceuticals Inc
  • InSight Biopharmaceuticals Ltd (Inactive)
  • Inspirna Inc
  • Integral Molecular Inc
  • Intensity Therapeutics Inc
  • Invectys SA
  • Inventiva SA
  • Invion Ltd
  • InxMed Shanghai Co Ltd
  • IO Biotech Inc
  • Ionic Pharmaceuticals LLC
  • Iovance Biotherapeutics Inc
  • iOx Therapeutics Ltd
  • Ipsen SA
  • iQ Group Global
  • ITM Isotopen Technologien Munchen AG
  • Jacobio Pharmaceuticals Group Co Ltd
  • January Therapeutics Inc
  • JenKem Technology Co Ltd
  • Jiangsu Hengrui Medicine Co Ltd
  • Jiangsu Kanion Pharmaceutical Co Ltd
  • Jina Pharmaceuticals Inc
  • Jivana Biotechnology Inc
  • JN Biosciences LLC
  • Johnson & Johnson
  • Jounce Therapeutics Inc
  • JSK Therapeutics Inc
  • Kalos Therapeutics Inc
  • Kangen Pharmaceuticals Co Ltd
  • Karyopharm Therapeutics Inc
  • Kenjockety Biotechnology Inc
  • KeViRX Inc
  • Kiadis Pharma NV
  • Kidswell Bio Corp
  • Kineta Inc
  • Kinnate Biopharma Inc
  • Kintara Therapeutics Inc
  • Kiromic BioPharma Inc
  • KLUS Pharma Inc
  • Komipharm International Co Ltd
  • Kong's Pharmaceutical
  • Kringle Pharma Inc
  • KSQ Therapeutics Inc
  • Kyowa Kirin Co Ltd
  • L.E.A.F. Pharmaceuticals LLC
  • Laekna Therapeutics Shanghai Co Ltd
  • Laevoroc Oncology AG
  • LaNova Medicines Ltd
  • Lantern Pharma Inc
  • Lassogen Inc
  • LATITUDE Pharmaceuticals Inc
  • Le Sun Pharmaceuticals Ltd
  • Leap Therapeutics Inc
  • Lee's Pharmaceutical Holdings Ltd
  • Legend Biotech Corp
  • LegoChem Biosciences Inc
  • Leucid Bio Ltd
  • Lin Bioscience Inc
  • Lipac Oncology LLC
  • Lipocure Ltd
  • Lipomedics Ltd
  • LipoSeuticals Inc
  • Livzon Pharmaceutical Group Co Ltd
  • Lixte Biotechnology Holdings Inc
  • Loki Therapeutics Inc
  • Lokon Pharma AB
  • Luminus Biosciences Inc
  • Lycera Corp
  • Lyvgen Biopharma Ltd
  • MabVax Therapeutics Holdings Inc
  • Machavert Pharmaceuticals LLC
  • MacroGenics Inc
  • Marino Biotechnology Co Ltd
  • MaxiVAX SA
  • MedGene Therapeutics Inc
  • MediaPharma SRL
  • Medicenna Therapeutics Corp
  • MediciNova Inc
  • Medicon Inc
  • MediGene AG
  • Meditope Biosciences Inc
  • Medolife Rx Inc
  • Merck & Co Inc
  • Merck KGaA
  • Mereo Biopharma Group Plc
  • Mersana Therapeutics Inc
  • MicroQuin Ltd
  • Midissia Therapeutics Inc
  • Millennium Pharmaceuticals Inc
  • Mina Therapeutics Ltd
  • Minerva Biotechnologies Corp
  • Mirati Therapeutics Inc
  • Modra Pharmaceuticals BV
  • Molecular Partners AG
  • Molecular Templates Inc
  • Moleculin Biotech Inc
  • Monarch Biosciences Inc
  • Monopar Therapeutics Inc
  • Monte Rosa Therapeutics Inc
  • Mosaic ImmunoEngineering Inc
  • Multitude therapeutics Inc
  • Mundipharma EDO GmbH
  • Mycenax Biotech Inc
  • Myeloid Therapeutics Inc
  • Nami Therapeutics Corp
  • Nammi Therapeutics Inc
  • Nanjing Aimeifei Biomedical Technology Co Ltd
  • Nanjing Bioheng Biotech Co Ltd
  • Nanjing CART Medical Technology Co Ltd
  • Nanjing Sanhome Pharmaceutical Co Ltd
  • Nanogenics Ltd
  • Nemucore Medical Innovations Inc
  • Neomics Pharmaceuticals LLC
  • Neosome Life Sciences LLC
  • NeoTX Therapeutics Ltd
  • Nerviano Medical Sciences SRL
  • NewBio Therapeutics Inc
  • NextCure Inc
  • NGM Biopharmaceuticals Inc
  • Ningbo Wenda Pharmaceutical Technology Co Ltd
  • Northlake International LLC
  • Northwest Biotherapeutics Inc
  • NovaRock Biotherapeutics Inc
  • Novartis AG
  • Noviga Research AB
  • Novita Pharmaceuticals Inc
  • NuCana Plc
  • Nurix Therapeutics Inc
  • Nuvation Bio Inc
  • Nuvectis Pharma Inc
  • Oasmia Pharmaceutical AB
  • OBI Pharma Inc
  • OBiO Technology (Shanghai) Corp Ltd
  • Ocellaris Pharma Inc
  • Omeros Corp
  • Omideon Ltd
  • Ona Therapeutics SL
  • OncoC4 Inc
  • Oncodesign SA
  • Oncoinvent AS
  • Oncomatryx Biopharma SL
  • Onconic Therapeutics Co Ltd
  • OncoOne Research & Development GmbH
  • OncoQuest Inc
  • OncoResponse Inc
  • OncoSynergy Inc
  • OncoTartis Inc
  • OncoTherapy Science Inc
  • Oncovir Inc
  • Oncoxx Biotech Srl
  • Oncternal Therapeutics
  • OncXerna Therapeutics Inc
  • ONK Therapeutics Ltd
  • Ono Pharmaceutical Co Ltd
  • Onxeo SA
  • Orano Med LLC
  • ORCA Therapeutics BV
  • Oregon Therapeutics
  • Orgenesis Inc
  • ORIC Pharmaceuticals Inc
  • Orpheus Therapeutics Inc
  • Oryx GmbH & Co KG
  • OS Therapies LLC
  • OSE Immunotherapeutics
  • Oxford BioMedica Plc
  • Oxford BioTherapeutics Ltd
  • Oxford Vacmedix UK Ltd
  • Pact Pharma Inc
  • Pai Life Sciences Inc
  • Palisades Therapeutics
  • Pamdeca LLC
  • Pan Cancer T BV
  • Panbela Therapeutics Inc
  • Pantarhei Oncology BV
  • Parasol Biotech Co Ltd
  • Patrys Ltd
  • PDS Biotechnology Corp
  • PEP-Therapy SAS
  • PepVax Inc
  • Pfizer Inc
  • Phanes Therapeutics Inc
  • Pharma Mar SA
  • PharmAbcine Inc
  • PharmAust Ltd
  • Pharmicell Co Ltd
  • Pharos iBio Co Ltd
  • Phi Pharma SA
  • Phio Pharmaceuticals Corp
  • Phosplatin Therapeutics LLC
  • PI Therapeutics Ltd
  • Pinotbio Inc
  • Pionyr Immunotherapeutics Inc
  • Placon Therapeutics Inc
  • Plexxikon Inc
  • Plus Therapeutics Inc
  • PLx Pharma Inc
  • Poseida Therapeutics Inc
  • Potenza Therapeutics Inc
  • Precigen Inc
  • Prelude Therapeutics Inc
  • Prescient Therapeutics Ltd
  • Prestige BioPharma Ltd
  • Primetime Life Sciences LLC
  • PRISM Pharma Co Ltd
  • Processa Pharmaceuticals Inc
  • ProLynx LLC
  • Propanc Biopharma Inc
  • Provectus Biopharmaceuticals Inc
  • Providence Therapeutics Inc
  • PsiOxus Therapeutics Ltd
  • PTC Therapeutics Inc
  • Puma Biotechnology Inc
  • Purple Biotech Ltd
  • Qilu Pharmaceutical Co Ltd
  • Qu Biologics Inc
  • Quadriga BioSciences Inc
  • Que Oncology Inc
  • QureBio Ltd
  • Qurient Co Ltd
  • Qwixel Therapeutics LLC
  • R-Pharm
  • R-Pharm US LLC
  • Race Oncology Ltd
  • Rain Therapeutics Inc
  • Regeneron Pharmaceuticals Inc
  • RemeGen Co Ltd
  • Repertoire Immune Medicines Inc
  • Rescue Therapeutics Inc
  • Reven Holdings Inc
  • Revere Pharmaceuticals Inc
  • Rhizen Pharmaceuticals SA
  • Richter Gedeon Nyrt
  • Ridgeline Therapeutics LLC
  • Rigel Pharmaceuticals Inc
  • Roivant Sciences Inc
  • RS Oncology LLC
  • RS Research
  • Rubicon Biotechnology Inc
  • Rubius Therapeutics Inc
  • RUS Pharmtech
  • Sagimet Biosciences
  • Salarius Pharmaceuticals Inc
  • Samyang Biopharmaceuticals Corp
  • Sanofi
  • Sapvax LLC
  • Sator Therapeutics LLC
  • Scancell Holdings Plc
  • Scandion Oncology AS
  • Seagen Inc
  • SELLAS Life Sciences Group Inc
  • Senhwa Biosciences Inc
  • Sequoia Sciences Inc
  • Shandong Boan Biotechnology Co Ltd
  • Shanghai Cell Therapy Group Co
  • Shanghai De Novo Pharmatech Co Ltd
  • Shanghai Escugen Biotechnology Co Ltd
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd
  • Shanghai GeneChem Co Ltd
  • Shanghai Haihe Biopharma Co Ltd
  • Shanghai Huilun Life Science & Technology Co Ltd
  • Shanghai Jiatan Pharmaceutical Technology Co Ltd
  • Shanghai Keqi Pharmaceutical Technology Co Ltd
  • Shanghai Miracogen Inc
  • Shanghai Novamab Biopharmaceuticals Co Ltd
  • Shanghai Pharmaceutical Group Co Ltd
  • Shanghai Yihao Biotechnology Co Ltd
  • Shattuck Labs Inc
  • Shenzen SiBiono GeneTech Co Ltd
  • Shenzhen Chipscreen Biosciences Co Ltd
  • Shorla Pharma Ltd
  • Siamab Therapeutics Inc (Inactive)
  • Sichuan Kangdesai Medical Technology Co Ltd
  • SideROS
  • Sierra Oncology Inc
  • SignalChem Lifesciences Corp
  • Simcha Therapeutics Inc
  • Sino Biopharmaceutical Ltd
  • siRNAgen Therapeutics Corp
  • Sitka Biopharma Inc
  • SL Bigen Co Ltd
  • SN BioScience
  • Sonoval LLC
  • Soricimed Biopharma Inc
  • Sorrento Therapeutics Inc
  • Sotio AS
  • Sphaera Pharma Pte Ltd
  • Splash Pharmaceuticals Inc
  • SpringWorks Therapeutics Inc
  • STADA Pharmaceuticals (Asia) Ltd
  • Starpharma Holdings Ltd
  • Statera BioPharma Inc
  • Stingthera Inc
  • Sumitomo Dainippon Pharma Co Ltd
  • Sumitomo Dainippon Pharma Oncology, Inc
  • Suntec Medical (Taiwan) Inc
  • SuperTrans Medical Ltd
  • Supratek Pharma Inc
  • Surface Oncology Inc
  • Susavion Biosciences Inc
  • Sutro Biopharma Inc
  • Suzhou Innovative Biomaterials & Pharmaceutics Co Ltd
  • Suzhou Maximum Bio-tech Co Ltd
  • Suzhou Stainwei Biotech Inc
  • Synergys Biotherapeutics Inc
  • Synermore Biologics Co Ltd
  • SynOx Therapeutics Ltd
  • Synthekine Inc
  • Syros Pharmaceuticals Inc
  • Systimmune Inc
  • T-Cure Bioscience Inc
  • Tactical Therapeutics Inc
  • Tactiva Therapeutics LLC
  • TAE Life Sciences LLC
  • Tagworks Pharmaceuticals BV
  • Taiho Pharmaceutical Co Ltd
  • Tailored Therapeutics LLC
  • Takeda Pharmaceutical Co Ltd
  • Takis Srl
  • Tango Therapeutics Inc
  • Targovax ASA
  • Tarus Therapeutics Inc
  • Tarveda Therapeutics Inc
  • TCR Cure Biopharma Technology Co Ltd
  • TCR2 Therapeutics Inc
  • Telix Pharmaceuticals Ltd
  • Tempest Therapeutics Inc
  • Temple Therapeutics BV
  • Tetranov International Inc
  • Theolytics Ltd
  • Theralink Technologies Inc
  • Theranano LLC
  • TheraTarget Inc
  • Theratechnologies Inc
  • Thetis Pharmaceuticals LLC
  • TILT Biotherapeutics Ltd
  • Tmunity Therapeutics Inc
  • Toray Industries Inc
  • TORL Biotherapeutics LLC
  • TOT Biopharm Co Ltd
  • TRACON Pharmaceuticals Inc
  • Tradewind BioScience Inc
  • Transcenta Holding Ltd
  • Transgene SA
  • TransGenex Nanobiotech Inc
  • Treos Bio Ltd
  • TVAX Biomedical Inc
  • Tyme Inc
  • Ube Industries Ltd
  • UBI Pharma Inc
  • Ultimovacs AS
  • United Immunity Co Ltd
  • Unleash Immuno Oncolytics Inc
  • Up Therapeutics Inc
  • VacV Biotherapeutics Ltd
  • ValiRx Plc
  • Vascular Biogenics Ltd
  • Vaxil Bio Therapeutics Ltd
  • VCN Biosciences SL
  • Vectorite Biomedical Inc
  • Venus Remedies Ltd
  • Verastem Inc
  • Verismo Therapeutics
  • Vertex Pharmaceuticals Inc
  • Veru Inc
  • Viatris Inc
  • Vigeo Therapeutics Inc
  • Vincerx Pharma Inc
  • Vivacitas Oncology Inc
  • VM Discovery Inc
  • Vyriad Inc
  • Wuhan YZY Biopharma Co Ltd
  • XEME BioPharma Inc
  • Xencor Inc
  • Xiangxue Life Sciences
  • XuanZhu Biological Technology Co Ltd
  • Xynomic Pharmaceuticals Holdings Inc
  • Yantai Rongchang Pharmaceutical Co Ltd
  • Yooyoung Pharm Co Ltd
  • Zenith Epigenetics Ltd
  • Zentalis Pharmaceuticals Inc
  • Zhejiang Hisun Pharmaceutical Co Ltd
  • ZielBio Inc
  • ZIOPHARM Oncology Inc
  • Zy Therapeutics Inc
  • Zymeworks Inc